Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 InflarxInfinity PharmaceuticalsElite PharmaceuticalsImmunicNeos Therapeutics
SymbolNASDAQ:IFRXNASDAQ:INFIOTCMKTS:ELTPNASDAQ:IMUXNASDAQ:NEOS
Price Information
Current Price$4.24$1.17$0.08$7.76$1.54
52 Week RangeHoldBuyN/ABuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyN/ABuyBuy
Consensus Price Target$12.50$3.25N/A$40.00$6.50
% Upside from Price Target194.81% upside177.78% upsideN/A415.46% upside322.08% upside
Trade Information
Market Cap$117.88 million$69 million$70.17 million$76.89 million$76.59 million
Beta-1.111.750.833.490.94
Average Volume533,711186,283857,99413,529264,852
Sales & Book Value
Annual RevenueN/A$22.15 million$7.57 millionN/A$49.99 million
Price / SalesN/A3.019.10N/A1.53
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$7.64 per share$0.92 per share($0.01) per share$11.73 per share$0.16 per share
Price / BookN/A1.27-8.20N/A9.63
Profitability
Net Income$-35,210,000.00$-11,250,000.00$-9,280,000.00$-41,470,000.00$-51,670,000.00
EPS($1.40)($0.20)N/A($35.60)($1.60)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/A∞N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-1,519.91%-40.58%N/A-35.77%
Return on Equity (ROE)-35.75%-125.37%N/A-92.16%-2,087.24%
Return on Assets (ROA)-32.84%-66.89%-24.26%-84.25%-22.93%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.11%N/AN/AN/A
Current Ratio7.81%6.22%1.17%4.91%1.11%
Quick Ratio7.81%6.22%0.68%4.91%0.91%
Ownership Information
Institutional Ownership Percentage19.53%49.70%0.01%21.17%43.60%
Insider Ownership PercentageN/A12.12%4.15%67.94%2.20%
Miscellaneous
Employees362543N/A215
Shares Outstanding25.96 million57.03 million840.40 million10.12 million49.73 million
Next Earnings Date3/26/2020 (Estimated)3/3/2020 (Confirmed)6/19/2020 (Estimated)3/2/2020 (Estimated)3/12/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel